The LDN 2017 Conference

We would like to thank all the speakers for taking part in the conference, and for their amazing presentations. 

Presentations on LDN pharmacology; the opioid system; and LDN’s role in treating autoimmune disorders eg Ehlers-Danlos Syndrome (EDS), eosinophilic esophagitis, myasthenia gravis, glycogen storage disorder (GSD VII), pemphigus vulgaris, Crackly Brain or Middle Ear Myoclonus (MEM), multiple sclerosis (MS), Parkinson’s, Lyme disease, Type 1 diabetes (T1DM), psoriasis and psoriatic arthritis, Crohn’s, vitiligo, cancer and cancer therapy, pain, CFS/ME, fibromyalgia, lupus, irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO); gut dysbiosis, nutrition, and gut healing; Vitamin D3, thyroid disorders, Hashimoto’s HIV/AIDS, hormone balance, autism, traumatic brain injury (TBI), post-traumatic stress disorders, pets, gastroparesis, rheumatoid arthritis, alcohol use disorder, phobias, children, complex regional pain syndrome (CPRS), celiac disease, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), ulcerative colitis, lichen, mental health and substance abuse disorders.

Using an Old Drug to Trick the Immune System into Healing Itself - Stephen Dickson, BSC (hons), MRPharmS


Treating the Zebras in Primary Care - Jill Cottel, MD


The Role of the Opioid System in Immune-Mediated Disease - Anthony Turel, MD


Multiple Sclerosis: Result-Based Immune Therapies Beyond Those Normally Offered - Paul S. Anderson, NMD


Q&A - The Q&A Panel


Modern Laboratory Tests for Diagnosing Lyme disease - Armin Schwarzbach, MD, PhD


Immune Dysfunction and Chronic Lyme Disease - Kent Holtorf, MD


A Novel Approach to Type 1 Diabetes Mellitus - Paul Battle, PA-C


Pediatric and Geriatric Dosing for LDN - Deanna Windham, DO


Psoriasis: A Novel Approach to Treatment - Deanna Windham, DO


Vitamin D and Autoimmune Disease: A Systematic Review of the Literature - Jill Cottel, MD


Q&A - The Q&A Panel


Understanding and Managing Neuropathic and Inflammatory Pain - Leonard Weinstock, MD


Beyond Tired: CFS/ME or Not? - Sarah Zielsdorf, MD, MS


The Ten Most Important Fibromyalgia Discoveries of 2016 and 2017 - Jarred Younger, PhD


Turning Down the Volume on Fibromyalgia Pain - Ginevra Liptan, MD


Q&A - The Q&A Panel


Irritable Bowel Syndrome: The Roles of Small Intestinal Bacterial Overgrowth (SIBO) and Mucosal/Systemic Inflammation - Leonard Weinstock, MD


Crohn's Disease: Latest Integrative Immunologic Therapies - Paul S. Anderson, NMD


An introduction to Fire in the Hole--Intestinal Permeability, The Development of Autoimmune Disease, and a Comprehensive Approach to Healing the Gut - Thomas O’Bryan, DC, CCN, DACBN


What the Bleep Can I Eat?! Making Sense of Conflicting Autoimmune Diets - Jill Brook, MA


The Role of Non-Cytotoxic Drugs in the Management of Cancer - Professor Angus Dalgleish


Broad spectrum, Gentler Anti-Neoplastics: Breaking the cycle of toxic therapy - Akbar Khan, MD


Q&A - The Q&A Panel


Thyroid Autoimmunity: Causal Relationships & Novel Therapeutics - John A. Robinson, NMD


Navigating the Narrative with your Health Care Team - Nasha Winters, ND


The low down on low dose naltrexone - Nasha Winters, ND


Review of Recent Statistics for Patients Taking LDN in a Special Needs Pediatric Practice - Brian Udell, MD


Opioid Antagonists and Traumatic Brain Injury - Ulrich Lanius, PhD and Galyn Forster, MS, LPC


A Medication to Gain Self-Awareness: Treatment of Dissociative Symptoms in Trauma-Related Disorders - Wiebke Pape, MD


A Guide to Testing Steroid and Peptide Hormones in Different Body Fluids - David Zava, PhD


LDN and Pets - Mark Mandel, PharmD


Q&A - The Q&A Panel


Gastroparesis - Beth Livengood, ND - Case Study - LDN 2017 Conference


Rheumatoid Arthritis - Beth Livengood, ND - Case Study - LDN 2017 Conference


Michael Ludwig, MS, PhD - Multiple Sclerosis


Paul S. Anderson, NMD - Cancer Presentation


Paul S. Anderson, NMD - Case Studies


Gaylyn Forster, MS, LPC - LDN for Mental Health Including Dosing


Sara J. Zielsdorf, MD, MS - Case Study - Hashimoto's


Darin Ingels, ND - Case Studies - Lyme Disease


Tom O'Bryan, DC, CCN, DACBN - Gut Healing


Galyn Forester, MS, LPC - Veterans with PTSD - 3 Case Studies


Armin Schwarzbach, MD, PhD - Lyme Borreliosis


Ginevra Liptan, MD - Fibromyalgia


Debbie Rice, ND - LDN regulating immune and inflammatory response


Jill Cottel, MD - Alcohol Use Disorder


Wiebke Pape, MD - Dissociative symptoms in trauma-related disorders


Galyn Forster, MS, LPC - An Introduction to Phobia of Shared Positive Affect


Darin Ingels, ND, BCIP LDN and Children


Leonard Weinstock, MD - Celiac Disease


Leonard Weinstock, MD - Inflammatory Bowel Disease


Leonard Weinstock, MD - Postural Orthostatic Tachycardia and Mast Cell Activation Syndromes


Jill Brook, MA - Dietary Strategies to Fight Autoimmunity


Paul Battle, PA-C - Possible Mechanisms of Naltrexone's Effects on Cancer


Laurie Marzell, ND, NCMP - LDN Cases #1-6


Brian Udell, MD - Low Dose Naltrexone & Autism Spectrum Disorder


Ulrich Lanius, PhD - Traumatic Stress and Dissociative Symptoms


Cory Tichauer, ND - LDN in a Complex Case of Lyme Disease With Co-Morbid Lupus, Asthma and Fibromyalgia


Deanna Windham, DO - Bipolar Presentation The Conundrum of Bipolar Disorder


Deanna Windham, DO - Lupus: A Misunderstood Disease


Pradeep Chopra, MD - Chronic Pain And LDN


John A. Robinson, NMD - Thyroid Disease: Optimizing Metabolism Through Comprehensive Hormonal Treatment


Mark Shukhman, MD - Low Dose Naltrexone (LDN) for Treatment of Postcoital Dysphoria


Samyadev Datta, MD, FRCA(Eng) - Use of Low Dose Naltrexone in Pain Management